Kenneth Allen Myszkowski, Chief Financial Officer at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 65,000 shares at $21.01 ($1.3M) on 2018-09-06, disclosed to the SEC on 2018-09-10.
Open-market sale of $1.3M ARWR by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.00 | 25,000 | $450K | 34.9% |
| 2 | $21.01 | 20,000 | $420K | 32.6% |
| 3 | $21.01 | 20,000 | $420K | 32.6% |
| Total | $19.85 avg | 65,000 | $1.3M | 100% |
| Filing → |
| ARWR | SELL | 2024-01-08 | $885K | — | Filing → |
| ARWR | SELL | 2023-06-29 | $543K | — | Filing → |
| ARWR | SELL | 2022-12-30 | $1.2M | — | Filing → |